For the quarter ending June 2022
North America
The market sentiments of Amoxicillin Trihydrate showcased fluctuating pricing trends in North America during the quarter second of 2022. The prices of Amoxicillin Trihydrate consistently soared till May and then dropped suddenly in June, backed by inconsistent downstream demand. The downstream inquiry for Amoxicillin Trihydrate from pharmaceutical industries to treat several bacterial infections such as pneumonia, tonsilitis, sinuses, etc., was strong till May, which later started depleting. Furthermore, the value of upstream Magnesium Stearate and Anhydrous Silica was escalating till May, raising the manufacturing cost of Amoxicillin Trihydrate, causing the price hike of Amoxicillin Trihydrate. Later, as the upstream cost reduced along with the deduction in downstream demand, the market value of Amoxicillin Trihydrate dropped considerably.
APAC
Mimicking the north American pricing trend, the price value of Amoxicillin Trihydrate fluctuated in the Asia-Pacific region during the second quarter of 2022, according to market perceptions. Amoxicillin Trihydrate prices rose steadily until May before abruptly falling in June, supported by erratic downstream demand. Until May, pharmaceutical firms had a significant need for Amoxicillin Trihydrate to treat various bacterial diseases, including tonsillitis, pneumonia, sinus infections, etc. However, demand has since begun to decline. Additionally, until May, the price of upstream ingredients such as magnesium stearate and anhydrous silica was rising, which increased the cost of producing Amoxicillin Trihydrate and thus led to an increase in the drug's price. Later, the market value of Amoxicillin Trihydrate significantly decreased as the upstream cost decreased and the downstream demand decreased.
Europe
Unlike North America and Asia-pacific, the market value of Amoxicillin Trihydrate soared consistently till June in the European countries during quarter 2 of 2022. However, the Amoxicillin Trihydrate price hike in April was much larger than in May and June. Upsurged downstream demand from pharma industries to cure diseases like pneumonia and tonsilitis readily contributed to the price rise of Amoxicillin Trihydrate in the domestic market. Furthermore, the escalated upstream cost on account of augmented raw material prices exacerbated the Amoxicillin Trihydrate's price value even more. Altogether, both the downstream offtake and manufacturing cost increased continuously in Europe during the quarter, eventually increasing Amoxicillin Trihydrate prices.
